1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
1. Cinpanemab did not show clinical efficacy in preventing early Parkinson’s disease (PD) progression compared to placebo. 2. There was ...
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were ...
1. Inpatient or outpatient clinic diagnosed influenza infection was associated with an increased odds ratio of diagnosis with Parkinson Disease ...
1. Patients that received deep brain stimulation (DBS) surgery demonstrated significantly greater decline in neuropsychological function within 6 months when ...
1. Deep brain stimulation (DBS) has established effectiveness in the treatment of medication-refractory Parkinson disease, and in patients with significant ...
1. Levodopa provided a small but consistent benefit for treatment of Parkinson’s disease as compared to levodopa-sparing regimens including dopamine ...
Feb 14th - Neurostimulation improved quality of life for Parkinson’s disease patients with early levodopa-induced motor complications. Image: CC/Hellerhoff 1. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.
Subscribe for free today!